SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Cantor Fitzgerald Healthcare Conference in New York, NY, on July 8, 2015.
Cantor Fitzgerald Healthcare Conference
Wednesday, July 8, 2015
1:00 pm Eastern Time / 10:00 am Pacific Time
New York City
The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at ir.zogenix.com.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 | Andrew@lifesciadvisors.com
Media: Catherine O'Connor
Sr. Director, Corporate Communications, Zogenix
858.436.3374 | firstname.lastname@example.orgZogenix, Inc.